Is Hypothyroidism Overlooked in Cardiac Surgery Patients?

Aarne Jyrala, Robert E. Weiss, Robin A. Jeffries, Gregory L. Kay

Heart Institute, Department of Cardiothoracic Surgery, Good Samaritan Hospital, Los Angeles.
Heart Institute, Department of Cardiothoracic Surgery, Good Samaritan Hospital, Los Angeles, USA.
School of Public Medicine, Department of Biostatistics, University of California, Los Angeles, USA.

DOI: 10.4236/ojts.2012.22009                

Abstract

Objectives: to analyze adequacy of preoperative thyroid screening of cardiac surgery patients (pts) with hypothyroidism (HT) and compare with pts without HT by demographic data, EuroSCORE (ES) scores, early and late outcomes. Patients: From 1000 cardiac surgery pts from Jan 1999 through May 2000 pts with HT were identified (Group 1, n = 80). 920 pts (Group 2) had no HT. Results Group 1 pts were older (p < 0.0001), had more females (p < 0.0001), more pts with CHF p < 0.0001, more pts in NYHA class III-IV (p = 0.01) and higher ES risk scores by both algorithms (p = 0.003 and p < 0.0001 consecutively) than Group 2 pts. ES variables demonstrated higher number of pts >60 years (p = 0.004), more females (p < 0.0001) and higher number of other than CABG surgery pts (p = 0.01) in Group 1. 47 (58.8%) had adequate laboratory tests. 15 (18.8%) had no tests and 18 (22.5%) inadequate tests. 10 (12.5%) pts had no replacement therapy. There was no operative mortality in Group 1 and 14 (1.5%) in Group 2 (p = 0.70). Hospital mortality was higher in Group 1 (6/7.5% vs 37/4.5%), p = 0.03. Stay in postoperative intensive care unit and hospital were similar (p = 0.66 and 0.53). More pts in Group 1 needed prolonged ICU and LOS (p < 0.0001 for both). Occurrence of postoperative AF was higher in Group 1, p < 0.02. Seventeen pts (23.0%) were not discharged home in Group 1 and 87 (10.2%) in Group 2, (p = 0.002). Follow-up mortality was higher in Group 1 (45/58.1% vs 378/43.5%, p = 0.02). Conclusions HT is overlooked in cardiac surgery patients. Long-term mortality is higher in pts with HT. Resource utilization is higher in pts with HT.

Keywords

Hypothyroidism; Cardiac Surgery; Outcome Differences

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	C. G. Roberts and P. W. Ladenson, “Hypothyroidism,” Lancet, Vol. 363, No. 9411, 2004, pp. 793-803. doi:10.1016/S0140-6736(04)15696-1
[2]	T. H. Jones, S. M. Hunter, A. Price and G. D. Angelini, “Should Thyroid Function Be Assessed before Cardiopulmonary Bypass Operations?” The Annals of Thoracic Surgery, Vol. 58, No. 2, 1994, pp. 434-436. doi:10.1016/0003-4975(94)92223-3
[3]	D. J. Drucker and G. N. Burrow, “Cardiovascular Surgery in Hypothyroid Patients,” Archives of Internal Medicine, Vol. 145, No. 9, 1985, pp. 1585-1587. doi:10.1001/archinte.1985.00360090049007
[4]	N. Stathatos and L. Wartofsky, “Perioperative Management of Patients with Hypothyroidism,” Endocrinology Metabolism Clinics of North America, Vol. 32, No. 2, 2003, pp. 503-518. doi:10.1016/S0889-8529(03)00007-0
[5]	A. R. Cappola and P. W. Ladenson, “Hypothyroidism and Atherosclerosis,” The Journal of Clinical Endocrinology & Metabolism, Vol. 88, No. 6, 2003, pp. 2438-2446. doi:10.1210/jc.2003-030398
[6]	B. Biondi and I. Klein, “Hypothyroidism as a Risk Factor for Cardiovascular Disease,” Endocrine, Vol. 24, No. 1, 2004, pp. 1-13. doi:10.1385/ENDO:24:1:001
[7]	S. Fazio, E. A. Palmieri, G. Lombardi and B. Biondi, “Effects of Thyroid Hormone on the Cardiovascular System,” Recent Progress in Hormone Research, Vol. 59, 2004, pp. 31-50. doi:10.1210/rp.59.1.31
[8]	P. Iglesias and J. J. Diez, “Thyroid Function and Kidney Disease,” European Journal of Endocrinology, Vol. 160, No. 4, 2009, pp. 503-515. doi:10.1530/EJE-08-0837
[9]	I. van Hoek and S. Daminet, “Interactions between Thyroid and Kidney Function in Pathological Conditions of These Organs: A Review,” General and Comparative Endocrinology, Vol. 160, No. 3, 2009, pp. 205-210. doi:10.1016/j.ygcen.2008.12.008
[10]	M. Suher, E. Koc, N. Ata and C. Ensari, “Relation of Thyroid Dysfunction, Thyroid Autoantibodies and Renal Function,” Renal Failure, Vol. 27, No. 6, 2005, pp. 739-742. doi:10.1080/08860220500243338
[11]	P. W. Ladenson, A. A. Levin, E. C. Ridgway and G. H. Daniels, “Complications of Surgery in Hypothyroid Patients,” The American Journal of Medicine, Vol. 77, No. 2, 1984, pp. 261-266. doi:10.1016/0002-9343(84)90701-0
[12]	A. U. Syed, A. F. El Watidy, A. N. Bhat, A. Wahba, R. M. El Oakley, I. Kiyai, E. A. Al Bukhari and M. R. Al Fagih, “Coronary Artery Bypass Surgery in Patients on Thyroxin Replacement Therapy,” Asian Cardiovascular & Thoracic Annals, Vol. 10, No. 2, 2002, pp. 107-110.
[13]	C. W. Hogue, L. L. Creswell, D. D. Gutterman and L. A. Fleisher, “Epidemiology, Mechanism and Risks. American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation after Cardiac Surgery,” Chest, Vol. 128, No. 2, 2005, pp. 9S-16S. doi:10.1378/chest.128.2_suppl.9S
[14]	J. D. Klempener, I. L. Klein, K. Ojamaa, R. E. Helm, M. Gomez, O. W. Isom and K. H. Krieger, “Triiodothyronine Therapy Lowers the Incidence of Atrial Fibrillation after Cardiac Operations,” The Annals of Thoracic Surgery, Vol. 61, No. 5, 1996, pp. 1323-1327. doi:10.1016/0003-4975(96)00102-6
[15]	L. Kokkonen, S. Majahalme, T. K??bi, V. Virtanen, J. Salmi, H. Huhtala, M. Tarkka and J. Mustonen, “Atrial Fibrillation in Elderly Patients after Cardiac Surgery Postoperative Hemodynamics and Low Postoperative Serum Triiodothyronine,” Journal of Cardiothoracic and Vascular Anesthesia, Vol. 19, No. 2, 2005, pp. 182-187. doi:10.1053/j.jvca.2005.01.028
[16]	D. Zindrou, K. M. Taylor and J. P. Bagger, “Excess Coronary Artery Bypass Graft Mortality among Women with Hypothyroidism,” The Annals of Thoracic Surgery, Vol. 74, No. 6, 2002, pp. 2121-2125. doi:10.1016/S0003-4975(02)04082-1